Migraine drug may soothe stubborn facial pain
NCT ID NCT07250984
First seen Jan 10, 2026 · Last updated Apr 24, 2026 · Updated 15 times
Summary
This study tests whether a migraine medication called ACMP (Eptinezumab) can reduce persistent facial pain that doesn't respond to usual treatments. Researchers believe the drug may work by calming overactive pain signals in the face, similar to how it helps migraines. Ten adults with facial pain will receive the drug intravenously, and their disability and pain levels will be measured over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIAL PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pain Therapy Clinic of University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.